Real-World Findings Support RASi Continuation in Advanced CKD Real-World Findings Support RASi Continuation in Advanced CKD
Discontinuing renin-angiotensin-system inhibitors in people with type 2 diabetes and chronic kidney disease can lead to a greater risk of adverse outcomes.First Look
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | Urology & Nephrology